The presence of FLT3-ITD in LSCs is associated with expression of CD123 [128,129], encoding the IL3 receptor subunit alpha (IL-3RA) which is overexpressed in 45% of AML patients. The gene discussed is FLT3; the disease is acute myeloid leukemia.